Literature DB >> 19751769

Reversal of learning deficits in hAPP transgenic mice carrying a mutation at Asp664: a role for early experience.

Junli Zhang1, Olivia F Gorostiza, Huidong Tang, Dale E Bredesen, Veronica Galvan.   

Abstract

In addition to the cleavages that generate amyloid-beta (Abeta), the Abeta-precursor protein (APP) is processed at Asp664, releasing a second toxic peptide (APP-C31). Transgenic mice otherwise identical to a well-characterized model of AD, PDAPP mice, but carrying a mutation that obliterates Asp664 show a reversal of AD-like deficits in memory and in non-cognitive components of behaviour in spite of accumulating high levels of Abeta. These results suggest that cleavage of APP at Asp664 plays a role in the generation of AD-like deficits, and that a major pathway of Abeta toxicity in vivo, or a pathway that crucially impinges on it, may depend on cleavage of APP at Asp664. Since young PDAPP(D664A) mice showed an akinetic phenotype when first required to swim, we trained a 3-month-old (mo) cohort to criterion (normal swimming), and briefly exposed it to the Morris water maze (MWM) environment prior to training at 7 mo, to avoid potentially confounding effects of the akinetic phenotype in MWM studies. Prior experience decreased floating in PDAPP(D664A) mice but not in PDAPP nor in non-Tg groups. While learning was restored in experienced PDAPP(D664A) mice, it was indistinguishable from both non-Tg as well as from PDAPP mice in naïve PDAPP(D664A) animals. Floating did not correlate with worse performance in naïve PDAPP(D664A) mice, suggesting that the contribution of prior experience to improved performance is related to its cognitive effects but not to non-cognitive components of behaviour. Our results suggest that early experience reduces the contribution of non-cognitive components of behaviour to performance, and may contribute to the restoration of learning at later ages in PDAPP(D664A) mice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19751769      PMCID: PMC2783897          DOI: 10.1016/j.bbr.2009.09.013

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  31 in total

1.  Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I.

Authors:  A Kamal; G B Stokin; Z Yang; C H Xia; L S Goldstein
Journal:  Neuron       Date:  2000-11       Impact factor: 17.173

2.  A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease.

Authors:  G Chen; K S Chen; J Knox; J Inglis; A Bernard; S J Martin; A Justice; L McConlogue; D Games; S B Freedman; R G Morris
Journal:  Nature       Date:  2000 Dec 21-28       Impact factor: 49.962

3.  High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.

Authors:  L Mucke; E Masliah; G Q Yu; M Mallory; E M Rockenstein; G Tatsuno; K Hu; D Kholodenko; K Johnson-Wood; L McConlogue
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

4.  A scaffold protein JIP-1b enhances amyloid precursor protein phosphorylation by JNK and its association with kinesin light chain 1.

Authors:  Hidehiko Inomata; Yoshitaka Nakamura; Akira Hayakawa; Hiroyuki Takata; Toshiharu Suzuki; Keiji Miyazawa; Naomi Kitamura
Journal:  J Biol Chem       Date:  2003-03-28       Impact factor: 5.157

5.  Interaction of ASK1 and the beta-amyloid precursor protein in a stress-signaling complex.

Authors:  Veronica Galvan; Surita Banwait; Patricia Spilman; Olivia F Gorostiza; Alyson Peel; Marina Ataie; Danielle Crippen; Wei Huang; Gurleen Sidhu; Hidenori Ichijo; Dale E Bredesen
Journal:  Neurobiol Dis       Date:  2007-07-03       Impact factor: 5.996

6.  Netrin-1 interacts with amyloid precursor protein and regulates amyloid-beta production.

Authors:  F C Lourenço; V Galvan; J Fombonne; V Corset; F Llambi; U Müller; D E Bredesen; P Mehlen
Journal:  Cell Death Differ       Date:  2009-01-16       Impact factor: 15.828

Review 7.  Neurobehavioral assessment in the information age.

Authors:  Laurence H Tecott; Eric J Nestler
Journal:  Nat Neurosci       Date:  2004-05       Impact factor: 24.884

8.  Long-term prevention of Alzheimer's disease-like behavioral deficits in PDAPP mice carrying a mutation in Asp664.

Authors:  Veronica Galvan; Junli Zhang; Olivia F Gorostiza; Surita Banwait; Wei Huang; Marina Ataie; Huidong Tang; Dale E Bredesen
Journal:  Behav Brain Res       Date:  2008-04-08       Impact factor: 3.332

9.  Caspase cleavage of the amyloid precursor protein modulates amyloid beta-protein toxicity.

Authors:  Daniel C Lu; Salvador Soriano; Dale E Bredesen; Edward H Koo
Journal:  J Neurochem       Date:  2003-11       Impact factor: 5.372

10.  Developments of a water-maze procedure for studying spatial learning in the rat.

Authors:  R Morris
Journal:  J Neurosci Methods       Date:  1984-05       Impact factor: 2.390

View more
  10 in total

1.  Chronic rapamycin restores brain vascular integrity and function through NO synthase activation and improves memory in symptomatic mice modeling Alzheimer's disease.

Authors:  Ai-Ling Lin; Wei Zheng; Jonathan J Halloran; Raquel R Burbank; Stacy A Hussong; Matthew J Hart; Martin Javors; Yen-Yu Ian Shih; Eric Muir; Rene Solano Fonseca; Randy Strong; Arlan G Richardson; James D Lechleiter; Peter T Fox; Veronica Galvan
Journal:  J Cereb Blood Flow Metab       Date:  2013-06-26       Impact factor: 6.200

2.  Rescue from excitotoxicity and axonal degeneration accompanied by age-dependent behavioral and neuroanatomical alterations in caspase-6-deficient mice.

Authors:  Valeria Uribe; Bibiana K Y Wong; Rona K Graham; Corey L Cusack; Niels H Skotte; Mahmoud A Pouladi; Yuanyun Xie; Konstantin Feinberg; Yimiao Ou; Yingbin Ouyang; Yu Deng; Sonia Franciosi; Nagat Bissada; Amanda Spreeuw; Weining Zhang; Dagmar E Ehrnhoefer; Kuljeet Vaid; Freda D Miller; Mohanish Deshmukh; David Howland; Michael R Hayden
Journal:  Hum Mol Genet       Date:  2012-01-18       Impact factor: 6.150

Review 3.  Importance of the caspase cleavage site in amyloid-β protein precursor.

Authors:  Dale E Bredesen; Varghese John; Veronica Galvan
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

4.  Cleavage at the 586 amino acid caspase-6 site in mutant huntingtin influences caspase-6 activation in vivo.

Authors:  Rona K Graham; Yu Deng; Jeffery Carroll; Kuljeet Vaid; Catherine Cowan; Mahmoud A Pouladi; Martina Metzler; Nagat Bissada; Lili Wang; Richard L M Faull; Michelle Gray; X William Yang; Lynn A Raymond; Michael R Hayden
Journal:  J Neurosci       Date:  2010-11-10       Impact factor: 6.167

5.  Palmitoylation of caspase-6 by HIP14 regulates its activation.

Authors:  Niels H Skotte; Shaun S Sanders; Roshni R Singaraja; Dagmar E Ehrnhoefer; Kuljeet Vaid; Xiaofan Qiu; Srinivasaragavan Kannan; Chandra Verma; Michael R Hayden
Journal:  Cell Death Differ       Date:  2016-12-02       Impact factor: 15.828

6.  Chronic inhibition of mammalian target of rapamycin by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in mice.

Authors:  J Halloran; S A Hussong; R Burbank; N Podlutskaya; K E Fischer; L B Sloane; S N Austad; R Strong; A Richardson; M J Hart; V Galvan
Journal:  Neuroscience       Date:  2012-06-28       Impact factor: 3.590

7.  Many neuronal and behavioral impairments in transgenic mouse models of Alzheimer's disease are independent of caspase cleavage of the amyloid precursor protein.

Authors:  Julie A Harris; Nino Devidze; Brian Halabisky; Iris Lo; Myo T Thwin; Gui-Qiu Yu; Dale E Bredesen; Eliezer Masliah; Lennart Mucke
Journal:  J Neurosci       Date:  2010-01-06       Impact factor: 6.167

8.  Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease.

Authors:  Patricia Spilman; Natalia Podlutskaya; Matthew J Hart; Jayanta Debnath; Olivia Gorostiza; Dale Bredesen; Arlan Richardson; Randy Strong; Veronica Galvan
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

Review 9.  Amyloid β precursor protein as a molecular target for amyloid β--induced neuronal degeneration in Alzheimer's disease.

Authors:  Elena Anahi Bignante; Florencia Heredia; Gerardo Morfini; Alfredo Lorenzo
Journal:  Neurobiol Aging       Date:  2013-05-25       Impact factor: 4.673

10.  The amyloid precursor protein intracellular domain-fe65 multiprotein complexes: a challenge to the amyloid hypothesis for Alzheimer's disease?

Authors:  Daniel A Bórquez; Christian González-Billault
Journal:  Int J Alzheimers Dis       Date:  2012-02-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.